The Food and Drug Administration's authorization of a COVID-19 vaccine could come in a day or two, a member of an FDA expert panel says. But he says it may be late 2021 before normalcy returns.
The Food and Drug Administration finds "no specific safety concerns" that would stand in the way of authorization of the vaccine for emergency use. Effectiveness is 95% after two doses.
The experimental cocktail from the biotech company Regeneron is the same drug President Trump got when he was battling the coronavirus this year. It is designed for mild to moderate cases.
The vaccine was found to be 95% effective in an updated study analysis. Safety data required by the Food and Drug Administration showed no serious concerns, the company said.
Eli Lilly's monoclonal antibody will be available to people 65 or older or those with underlying health conditions. Supplies will be short, and allocating the medicine will be a challenge.
A panel of doctor and scientists raised questions about the expedited regulatory path the Food and Drug Administration is considering for COVID-19 vaccines.
Pfizer Chairman and CEO Albert Bourla said in a public statement Friday that the company won't have data showing that the vaccine is safe before the third week of November at the earliest.
The requirements laid out by the Food and Drug Administration in advice for drugmakers underscore why it's unlikely a vaccine could clear the agency before Election Day.
An Atlanta plastic surgeon is recruiting patients to study the impact of breast implants. This comes after the U.S. Food and Drug Administration issues its strongest warning yet for all breast implant products. GPB’s Ellen Eldridge reports.
An NPR investigation has identified a web of more than 30 medical practices and compounding pharmacies in over a dozen states that have made claims about thymosin alpha-1 online and on social media.
Friday on Political Rewind: The Centers for Disease Control and Prevention (CDC) has been the gold standard of global public health organizations for many decades. But recent efforts to marginalize and undermine such trusted public health agencies — including the U.S. Food and Drug Administration (FDA) — are complicating the COVID-19 response.
How does this affect Americans' perceptions and the country's ability to combat coronavirus, particularly when a vaccine does become available? We discuss the politicization of a pandemic.
Scientists are racing to develop a vaccine that proves "safe and effective." It may not prevent infection in everyone who gets it, but it still could eventually stop the pandemic. Here's how.
Several COVID-19 vaccine candidates are being tested now. But why does it take 30,000 volunteers to know if one is safe and effective? And what does it mean to say a vaccine candidate is working?
